DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo


company name or ticker

Benzinga's M&A Chatter for Tuesday June 3, 2014

Teva Pharmaceutical's (TEVA) Management Presents at Jefferies Global Healthcare Conference (Transcri

Teva Pharmaceutical's (TEVA) Management Presents at Jefferies Global Healthcare Conference (Transcript)

Teva to Acquire Labrys Biologics, Inc

Actavis Acquires Forest Labs For Brand-Name Drugs

Why Teva Pharmaceuticals (TEVA) Stock Is Up Today

Teva Announces New Organizational Structure and Senior Leadership Changes; Appoints New Global Head

Teva Announces New Organizational Structure and Senior Leadership Changes; Appoints New Global Head of Quality

Teva Pharma: Underpriced And Misunderstood, Identifiable Catalyst

Healthcare Stocks Inching Higher; Mylan Still Looking to Overturn FDA Decision Supporting Teva Exclu

Healthcare Stocks Inching Higher; Mylan Still Looking to Overturn FDA Decision Supporting Teva Exclusivity Period

Sector Update: Healthcare

Teva Receives Favorable Court Decision Regarding Generic Celebrex Capsules; Teva Should Receive Sole

Teva Receives Favorable Court Decision Regarding Generic Celebrex Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex Capsules
See More Articles...